1. Home
  2. KLTR vs SPRO Comparison

KLTR vs SPRO Comparison

Compare KLTR & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

HOLD

Current Price

$1.51

Market Cap

218.0M

Sector

Technology

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.70

Market Cap

135.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLTR
SPRO
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.0M
135.5M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
KLTR
SPRO
Price
$1.51
$2.70
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
510.3K
408.3K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
111.81
EPS
N/A
N/A
Revenue
$180,854,000.00
$66,802,000.00
Revenue This Year
$2.96
N/A
Revenue Next Year
$4.96
$300.00
P/E Ratio
N/A
$16.23
Revenue Growth
1.20
39.24
52 Week Low
$1.06
$0.65
52 Week High
$2.27
$3.09

Technical Indicators

Market Signals
Indicator
KLTR
SPRO
Relative Strength Index (RSI) 63.10 56.63
Support Level $1.39 $2.15
Resistance Level $1.63 $2.70
Average True Range (ATR) 0.10 0.14
MACD 0.01 -0.01
Stochastic Oscillator 82.00 85.53

Price Performance

Historical Comparison
KLTR
SPRO

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: